Brian is a managing partner in the San Francisco office and focuses on investments in healthcare companies. He joined Polaris as an associate in Boston, shortly after the firm was founded in 1996. Brian works with several Polaris portfolio companies including Ajax Health, August Bioservices, Neumora Therapeutics, Nomad Health, and Quartet Health, and serves as chair of Lola Development and US HealthVest.
Brian is a decorated veteran, having served as Captain in the US Army Corps of Engineers. His service included the command of combat engineer soldiers during the Gulf War. As platoon leader, Brian was awarded the Bronze Star and the Army Commendation Medal with Valor for successfully completing missions while encountering enemy fire on the front lines. Brian currently serves as a mentor with ACP helping veterans find their next career.
On behalf of Polaris, Brian has been a director of Ascend Health (Universal Health Services), Asthmatx (Boston Scientific), BridgePoint Medical (Boston Scientific), Data Sciences International (Harvard Bioscience), Free & Clear (Alere Health/United Health Group), PartsSource (Great Hill Partners), Respicardia (Zoll Medical), and Sentillion (Microsoft).
Prior to Polaris, Brian gained experience in the New York and San Francisco offices of Goldman Sachs and at Baxter Healthcare, a global, diversified healthcare company, with expertise in medical devices, pharmaceuticals, and biotechnology.
Brian received his BS from the United States Military Academy at West Point and his MBA from the Tuck School of Business at Dartmouth College.
The endorsements of current or past portfolio company executives are provided as illustrative examples and designed to demonstrate the benefits to portfolio companies of partnering with us. These statements are primarily aimed at prospective portfolio companies and not intended to solicit investors. The portfolio companies covered in these endorsements do not represent all portfolio company investments we have made. The experiences highlighted in these testimonials are solely those of the executives profiled and may not necessarily represent or be indicative of the current, past, or future experiences of other portfolio companies. Past results and experiences discussed are not indicative, or a guarantee of future results and experiences. We have not provided cash or other type of compensation in exchange for receiving these endorsements. We do not believe there are typically any material conflicts associated with providing these endorsements. The compensation of our portfolio company executives is primarily driven by the performance of their respective portfolio companies and any discretion we exercise in such compensation determinations is not influenced by whether an executive has provided a favorable statement. Additionally, the economic interests of our portfolio companies’ executives are generally well-aligned with ours and those of our investors. Nevertheless, the fact that these endorsements have been provided by individuals whose compensation we exercise a certain level of control over may incentivize them to provide favorable evaluations of their experiences working with us.